Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CASR | P41180 | 2/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL343726 | 1.00 | AOC3 (0.57) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL43520 | 1.00 | AOC3 (0.57) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL2608969 | 0.86 | AOC3 (0.58) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL6912472 | 0.85 | PTGS1 (0.58) | AOC3L3MBTL1UGT2B7ACHE | |
| SCHEMBL6912468 | 0.85 | PTGS1 (0.58) | AOC3L3MBTL1UGT2B7ACHE | |
| SCHEMBL2093768 | 0.85 | AOC3 (0.59) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL2087869 | 0.85 | AOC3 (0.59) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL11604883 | 0.85 | AOC3 (0.62) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL24925808 | 0.84 | AOC3 (0.54) | AOC3L3MBTL1CASRCHRM2CHRM1 | |
| SCHEMBL18793772 | 0.84 | AOC3 (0.54) | AOC3L3MBTL1CASRCHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011028-A | Method for efficiently preparing various substituted chiral phosphoramides | 上海交通大学 | 2026-05-12 | — | — | CN | claimed |
| CN-114292385-B | Nitrogen-containing porous organic polymer composite material and preparation method and application thereof | 苏州大学 | 2023-09-05 | — | — | CN | claimed |
| WO-2023123126-A1 | NITROGEN-CONTAINING POROUS ORGANIC POLYMER COMPOSITE MATERIAL AND PREPARATION METHOD AND APPLICATION THEREOF | 苏州大学 | 2023-07-06 | — | — | WO | claimed |
| CN-110002961-B | Method for racemization-free synthesis of chiral alcohol | 三峡大学 | 2022-05-03 | — | — | CN | claimed |
| CN-114292385-A | Nitrogen-containing porous organic polymer composite material and preparation method and application thereof | 苏州大学 | 2022-04-08 | — | — | CN | claimed |
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | claimed |
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-12-10 | — | — | US | claimed |
| CN-101580482-A | Method for preparing rivastigmine hydrogen tartrate and application thereof | UNIV SHENYANG PHARMACEUTICAL (CN) | 2009-11-18 | — | — | CN | claimed |
| US-6613317-B1 | In particular northern corn rootworm | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2003-09-02 | — | — | US | claimed |
| CN-122011028-A | Method for efficiently preparing various substituted chiral phosphoramides | 上海交通大学 | 2026-05-12 | — | — | CN | disclosed |
| CN-120040353-A | Nitrogen-containing heteroaryl compound, and preparation method and application thereof | 江苏恩华药业股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119798058-A | Preparation method of alpha-alkyl ketone derivative | 浙江工业大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119491240-A | Method for preparing benzyl carboxylic acid compound by taking carbon dioxide as raw material | 哈尔滨工业大学（深圳） | 2025-02-21 | — | — | CN | disclosed |
| CN-116693467-B | Thiazole amine MBL inhibitor and preparation method and application thereof | 四川大学 | 2025-02-14 | — | — | CN | disclosed |
| US-5238938-A | Nephrosis | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0411150-A1 | INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-02-06 | — | — | EP | disclosed |
| EP-0371733-A2 | Dopamine-beta-hydroxylase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1990-06-06 | — | — | EP | disclosed |
| EP-0149976-A2 | Substituted imidazoles | CIBA-GEIGY AG (CH) | 1985-07-31 | — | — | EP | disclosed |
| US-4346242-A | Method for preparing substituted meta-phenylalkoxynitrobenzenes | AMERICAN CYANAMID COMPANY (US) | 1982-08-24 | — | — | US | disclosed |
| US-4094994-A | ANTICANCER AGENTS, TUMOR INHIBITION, HORMONE-DEPENDENT CARCINOMAS | KLINGE PHARMA GMBH (DT) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200384451-A1 | PHOSPHINE FREE COBALT BASED CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | CPNE4, PPOX, PDCD5 | AOC3 853/4885L3MBTL1 4818/4885CASR 4183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.